¼¼°èÀÇ È­ÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤±â ½ÃÀå º¸°í¼­ : µ¿Çâ, ¿¹Ãø ¹× °æÀï ºÐ¼®(-2030³â)
Chemiluminescence Immunoassay Analyzer Market Report: Trends, Forecast and Competitive Analysis to 2030
»óǰÄÚµå : 1417531
¸®¼­Ä¡»ç : Lucintel
¹ßÇàÀÏ : 2024³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 150 - page report
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,850 £Ü 7,017,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,800 £Ü 8,392,000
PDF (2 Users License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 2¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,700 £Ü 9,694,000
PDF (5 Users License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,850 £Ü 12,805,000
PDF (Corporate License) help
PDF º¸°í¼­¸¦ ±â¾÷ ³» ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÀÌ¿ë Àοø¿¡ Á¦ÇÑÀº ¾øÀ¸³ª, ±¹³»¿¡ ÀÖ´Â »ç¾÷À常 ÇØ´çµÇ¸ç, ÇØ¿Ü ÁöÁ¡ µîÀº Æ÷ÇÔµÇÁö ¾Ê½À´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

È­ÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤±âÀÇ µ¿Çâ°ú Àü¸Á

È­ÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤±â ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö 6.6%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î 2030³â±îÁö ¾à 200¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº ±Þ¼º ¹× ¸¸¼º ÁúȯÀÇ ÀÌȯÀ² Áõ°¡, È­ÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤±â(CLIA) ±â¼ú °³¹ßÀÇ °¡¼ÓÈ­, ¸¸¼º ÁúȯÀÇ Á¶±â ¹ß°ßÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö´Â °ÍÀÔ´Ï´Ù. È­Çй߱¤ ¸é¿ªÃøÁ¤ Àåºñ ¼¼°è ½ÃÀåÀÇ ¹Ì·¡´Â º´¿ø, Á¦¾à ¹× »ý¸í°øÇÐ ±â¾÷, ÀÓ»ó½ÇÇè½Ç ½ÃÀå¿¡¼­ÀÇ ±âȸ·Î ÀÎÇØ À¯¸ÁÇÑ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

È­Çй߱¤ ¸é¿ª ÃøÁ¤±â ½ÃÀå ÀλçÀÌÆ®

LucintelÀº ¾Ï ȯÀÚ Áõ°¡¿Í ½ÅÈï±¹¿¡¼­ÀÇ ¾Ï ¹ß°ß¿¡ ´ëÇÑ Áö½Ä Áõ°¡·Î ÀÎÇØ ¾Ï ºÐ¾ß°¡ ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« ºÎ¹®À¸·Î ³²À» °ÍÀ¸·Î ¿¹»óÇϰí ÀÖ½À´Ï´Ù.

ºÏ¹Ì´Â ¹Ì±¹, ij³ª´Ù µîÀÇ ±¹°¡¿¡¼­ ±¸Á¶È­µÈ ÀÇ·á ÀÎÇÁ¶ó ½Ã¼³¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ ¿ëÀÌÇϰí, È­Çй߱¤ ¸é¿ª ÃøÁ¤ ÀåÄ¡ °ü·Ã ¿¬±¸ Ȱµ¿¿¡ ´ëÇÑ Á¤ºÎ ÀÚ±ÝÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È °¡Àå ±Ô¸ð°¡ Å« Áö¿ªÀ¸·Î ³²À» °ÍÀÔ´Ï´Ù.

ÀÚÁÖ ¹¯´Â Áú¹®

Q1. ½ÃÀå ±Ô¸ð´Â?

A1. È­ÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤ Àåºñ ¼¼°è ½ÃÀåÀº 2030³â±îÁö ¾à 200¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Q2. ½ÃÀå ¼ºÀå Àü¸ÁÀº?

A2. È­ÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤ Àåºñ ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 6.6%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Q3. ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ÃËÁø¿äÀÎÀº ¹«¾ùÀΰ¡?

A3.ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº ±Þ¼º ¹× ¸¸¼º ÁúȯÀÇ ÀÌȯÀ² Áõ°¡, È­ÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤ ÀåÄ¡(CLIA) ±â¼ú °³¹ßÀÇ °¡¼ÓÈ­, ¸¸¼º ÁúȯÀÇ Á¶±â ¹ß°ßÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö´Â °ÍÀÔ´Ï´Ù.

Q4. ½ÃÀåÀÇ ÁÖ¿ä ºÎ¹®Àº?

A4. ¼¼°è È­Çй߱¤ ¸é¿ª ÃøÁ¤±â ½ÃÀåÀÇ ¹Ì·¡´Â º´¿ø, Á¦¾à ¹× ¹ÙÀÌ¿À ±â¾÷, ÀÓ»ó °Ë»ç ½ÃÀå¿¡¼­ À¯¸ÁÇÕ´Ï´Ù.

Q5. ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº?

A5. È­ÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤ Àåºñ ÁÖ¿ä ±â¾÷Àº ´ÙÀ½°ú °°½À´Ï´Ù.

Q6. ÇâÈÄ °¡Àå Å« ½ÃÀå ºÎ¹®Àº?

A6.LucintelÀº ¾Ï ȯÀÚ Áõ°¡¿Í ½ÅÈï±¹¿¡¼­ÀÇ ¾Ï °ËÃâ¿¡ ´ëÇÑ Áö½Ä Áõ°¡·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È ¾Ï ºÐ¾ß°¡ ´õ Å« ºÎ¹®À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óÇϰí ÀÖ½À´Ï´Ù.

Q7. ÇâÈÄ 5³â°£ °¡Àå Å« ½ÃÀåÀ¸·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â Áö¿ªÀº?

A7. ºÏ¹Ì´Â ¹Ì±¹, ij³ª´Ù¿Í °°Àº ±¹°¡¿¡¼­ ±¸ÃàµÈ ÇコÄɾî ÀÎÇÁ¶ó ½Ã¼³¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ ¿ëÀÌÇϰí, È­Çй߱¤ ¸é¿ª ÃøÁ¤ ÀåÄ¡ °ü·Ã ¿¬±¸ Ȱµ¿¿¡ ´ëÇÑ Á¤ºÎ ÀÚ±ÝÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È °¡Àå ±Ô¸ð°¡ Å« Áö¿ªÀ¸·Î ³²¾ÆÀÖÀ» °ÍÀÔ´Ï´Ù.

Q8. º¸°í¼­ Ä¿½ºÅ͸¶ÀÌ¡ÀÌ °¡´ÉÇѰ¡?

A8. ³×. LucintelÀº Ãß°¡ ºñ¿ë¾øÀÌ 10%ÀÇ »ç¿ëÀÚ Á¤ÀǸ¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°èÀÇ È­ÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤±â ½ÃÀå : ½ÃÀå ¿ªÇÐ

Á¦3Àå ½ÃÀå µ¿Çâ°ú ¿¹Ãø ºÐ¼®(2018-2030³â)

Á¦4Àå Áö¿ªº° ½ÃÀå µ¿Çâ°ú ¿¹Ãø ºÐ¼®(2018-2023³â)

Á¦5Àå °æÀï ºÐ¼®

Á¦6Àå ¼ºÀå ±âȸ¿Í Àü·« ºÐ¼®

Á¦7Àå À¯·Â ±â¾÷ °³¿ä

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Chemiluminescene Immunoassay Analyzer Trends and Forecast

The future of the global chemiluminescene immunoassay analyzer market looks promising with opportunities in the hospital, pharmaceutical & biotech firm, and clinical laboratories markets. The global chemiluminescene immunoassay analyzer market is expected to reach an estimated $20.0 billion by 2030 with a CAGR of 6.6% from 2024 to 2030. The major drivers for this market are rising rates of both acute and chronic illnesses, greater speed at which technology is developing for chemiluminescence immunoassay (CLIA) analyzers, as well as, the rising awareness of the importance of early identification of chronic diseases.

A more than 150-page report is developed to help in your business decisions.

Chemiluminescene Immunoassay Analyzer by Segment

The study includes a forecast for the global chemiluminescene immunoassay analyzer by product, application, end use, and region.

Chemiluminescene Immunoassay Analyzer Market by Product [Shipment Analysis by Value from 2018 to 2030]:

Chemiluminescene Immunoassay Analyzer Market by Application [Shipment Analysis by Value from 2018 to 2030]:

Chemiluminescene Immunoassay Analyzer Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

Chemiluminescene Immunoassay Analyzer Market by Region [Shipment Analysis by Value from 2018 to 2030]:

List of Chemiluminescene Immunoassay Analyzer Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies chemiluminescene immunoassay analyzer companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the chemiluminescene immunoassay analyzer companies profiled in this report include-

Chemiluminescene Immunoassay Analyzer Market Insights

Lucintel forecasts that oncology will remain the larger segment over the forecast period due to increase in cancer cases and growing knowledge of its detection in emerging nations.

North America will remain the largest region over the forecast period due to the easy accessibility of well-structured healthcare infrastructure facilities in nations such as the united states and canada, as well as an increase in government funding for research efforts connected to chemiluminescence immunoassay analyzers.

Features of the Global Chemiluminescene Immunoassay Analyzer Market

Market Size Estimates: Chemiluminescene immunoassay analyzer market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Chemiluminescene immunoassay analyzer market size by product, application, end use, and region in terms of value ($B).

Regional Analysis: Chemiluminescene immunoassay analyzer market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product, application, end use, and regions for the chemiluminescene immunoassay analyzer market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the chemiluminescene immunoassay analyzer market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the chemiluminescene immunoassay analyzer market size?

Answer: The global chemiluminescene immunoassay analyzer market is expected to reach an estimated $20.0 billion by 2030.

Q2. What is the growth forecast for chemiluminescene immunoassay analyzer market?

Answer: The global chemiluminescene immunoassay analyzer market is expected to grow with a CAGR of 6.6% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the chemiluminescene immunoassay analyzer market?

Answer: The major drivers for this market are rising rates of both acute and chronic illnesses, greater speed at which technology is developing for chemiluminescence immunoassay (CLIA) analyzers, as well as, the rising awareness of the importance of early identification of chronic diseases.

Q4. What are the major segments for chemiluminescene immunoassay analyzer market?

Answer: The future of the global chemiluminescene immunoassay analyzer market looks promising with opportunities in the hospital, pharmaceutical & biotech firm, and clinical laboratories markets.

Q5. Who are the key chemiluminescene immunoassay analyzer market companies?

Answer: Some of the key chemiluminescene immunoassay analyzer companies are as follows.

Q6. Which chemiluminescene immunoassay analyzer market segment will be the largest in future?

Answer: Lucintel forecasts that oncology will remain the larger segment over the forecast period due to increase in cancer cases and growing knowledge of its detection in emerging nations.

Q7. In chemiluminescene immunoassay analyzer market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to the easy accessibility of well-structured healthcare infrastructure facilities in nations such as the united states and canada, as well as an increase in government funding for research efforts connected to chemiluminescence immunoassay analyzers.

Q8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Table of Contents

1. Executive Summary

2. Global Chemiluminescene Immunoassay Analyzer Market : Market Dynamics

3. Market Trends and Forecast Analysis from 2018 to 2030

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

5. Competitor Analysis

6. Growth Opportunities and Strategic Analysis

7. Company Profiles of Leading Players

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â